Nuvation Bio to Present Pivotal IBTROZI® Data in TKI-Naïve and TKI-Pretreated Patients with Advanced ROS1-Positive Non-Small Cell Lung Cancer at AACR 2026 Nanotech Investing
Longeveron Announces 2025 Full Year Financial Results and Provides Business Update Nanotech Investing
Longeveron to Report 2025 Full-Year Financial Results and Host Conference Call on March 17, 2026 Nanotech Investing
Cullinan Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2025 Financial Results Nanotech Investing
Satellos Presents Interim SAT-3247 Clinical and Biomarker Data in Duchenne Muscular Dystrophy at the 2026 MDA Clinical & Scientific Conference Nanotech Investing
Anixa Biosciences Receives Notice of Allowance from Korean Ministry of Intellectual Property for Patent Covering Breast Cancer Vaccine Technology Nanotech Investing
Veru Enrolls First Patient in Phase 2b PLATEAU Clinical Trial of Enobosarm and Semaglutide Combination for High Quality Weight Loss Nanotech Investing
Allarity Therapeutics Closes $20 Million Financing to Accelerate the Advance of Stenoparib Toward FDA Approval and Commercialization Nanotech Investing
Caribou Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update Nanotech Investing
